TD Cowen Downgrades Medpace (MEDP) to Sell

TD Cowen analyst Charles Rhyee downgraded Medpace (NASDAQ: MEDP) from Hold to Sell with a price target of $366.00 (from $283.00).

The analyst comments "We are downgrading shares of MEDP to Sell from Hold, as we believe yesterday's 55% move reflects short covering rather than a material change in fundamentals. We see likely greater sustainability in both bookings and revenue growth beyond N12M than we had thought prior, and at min. the macro has stabilized. But at 31x revised '26 ests., we believe shrs are overvalued relative to expected growth."

For an analyst ratings summary and ratings history on Medpace click here. For more ratings news on Medpace click here.

Shares of Medpace closed at $477.73 yesterday.

You May Also Be Interested In

• Fiserv (FISV) PT Lowered to $60 at Freedom Broker
• Home Depot (HD) call put ratio 1.5 calls to 1 put with a focus on September 330 puts into quarter results
• Berkshire adds significantly to Alphabet position, starts small position in DR Horton